Patent · US Expired

Immunogenic recombinant antibody

US8034338B2 · kind B2 · utility

3Cited by

1References

6Claims

0Family size

Assignee

Igeneon Krebs-Immuntherapie Forschungs-und Entwicklungs-AG · AT

Inventors

Hans Loibner · Wien, AT
Gottfried Himmler · Groß-Enzersdorf, AT
Gunter Waxenecker · Mank, AT
Manfred Schuster · Schrick, AT
Thomas Putz · Innsbruck, AT

Key dates

Filing date	Apr 16, 2004
Grant date	Oct 11, 2011
Priority date	—
Expiry date	Dec 13, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention refers to an immunogenic recombinant antibody designed for immunization of primates comprising at least a part of a murine IgG2a subtype amino acid sequence and a mammalian glycosylation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.